Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients

Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome

(2010) M Carlsten et al.   LEUKEMIA

Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: implications for a phase I clinical study

(2009) Wendy Ingram et al.   BRITISH JOURNAL OF HAEMATOLOGY

Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors

(2009) Miroslaw J. Szczepanski et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines

(2009) Javier G. Casado et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells

(2009) M. Carlsten et al.   JOURNAL OF IMMUNOLOGY

DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases

(2009) C. J. Chan et al.   JOURNAL OF IMMUNOLOGY

Human natural killer cells

(2008) M. A. Caligiuri   BLOOD

Treatment of older adults with acute myeloid leukemia: state of the art and current perspectives

(2008) M. A. Sekeres   HAEMATOLOGICA

DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

(2008) Susan Gilfillan et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Natural Killer Cells in Innate Immunity and Cancer

(2008) Brian Becknell et al.   JOURNAL OF IMMUNOTHERAPY

NK cells and cancer immunosurveillance

(2008) I Waldhauer et al.   ONCOGENE